P-selectin glycoprotein ligand 1 and β2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor

Blood

Volumn 108, Issue 12, 2006, Pages 3746-3752

  Pendu, Ronan ^a   Terraube, Virginie ^a   Christophe, Olivier D ^a   Gahmberg, Carl G ^a   De Groot, Philip G ^a   Lenting, Peter J ^a   Denis, Cecile V ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA9BETA1 INTEGRIN; ALPHALBETA2 INTEGRIN; ALPHAMBETA2 INTEGRIN; ALPHAXBETA2 INTEGRIN; BETA1 INTEGRIN; BETA2 INTEGRIN; NEUTROPHIL INHIBITORY FACTOR; P SELECTIN GLYCOPROTEIN LIGAND 1; PHORBOL 13 ACETATE 12 MYRISTATE; RECOMBINANT P SELECTIN GLYCOPROTEIN LIGAND 1; RECOMBINANT PROTEIN; VERY LATE ACTIVATION ANTIGEN 4; VON WILLEBRAND FACTOR;

ARTICLE; BINDING SITE; CELL INTERACTION; CELL SURFACE; CELL TRANSPORT; CONTROLLED STUDY; HEMOSTASIS; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

EID: 33750688949     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-03-010322     Document Type: Article

References (40)

1. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-314.
2. McEver RP, Cummings RD. Perspectives series: cell adhesion in vascular biology: role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest. 1997;100:485-491.
3. Cerletti C, Evangelista V, de Gaetano G. P-selectin-beta 2-integrin cross-talk: a molecular mechanism for polymorphonuclear leukocyte recruitment at the site of vascular damage. Thromb Haemost. 1999;82:787-793.
4. Gahmberg CG. Leukocyte adhesion: CD11/CD18 integrins and intercellular adhesion molecules. Curr Opin Cell Biol. 1997;9:643-650.
5. Ugarova TP, Yakubenko VP. Recognition of fibrinogen by leukocyte integrins. Ann N Y Acad Sci. 2001;936:368-385.
6. Kanse SM, Matz RL, Preissner KT, Peter K. Promotion of leukocyte adhesion by a novel interaction between vitronectin and the β2 integrin Mac-1 (αMβ2, CD11b/CD18). Arterioscler Thromb Vasc Biol. 2004;24:2251-2256.
7. Santoso S, Sachs UJ, Kroll H, et al. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J Exp Med. 2002;196:679-691.
8. Simon DI, Chen Z, Xu H, et al. Platelet glycoprotein Ibα is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med. 2000;192:193-204.
9. Ruggeri ZM. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost. 2003;1:1335-1342.
10. Sadler JE. New concepts in von Willebrand disease. Annu Rev Med. 2005;56:173-191.
11. Denis CV, Wagner DD. Insights from von Willebrand disease animal models. Cell Mol Life Sci. 1999;56:977-990.
12. Denis CV, Andre P, Saffaripour S, Wagner DD. Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice. Proc Natl Acad Sci U S A. 2001;98:4072-4077.
13. Bonfanti R, Furie BC, Furie B, Wagner DD. PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells. Blood. 1989;73:1109-1112.
14. Denis CV. Molecular and cellular biology of von Willebrand factor. Int J Hematol. 2002;75:3-8.
15. Methia N, Andre P, Denis CV, Economopoulos M, Wagner DD. Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. Blood. 2001;98:1424-1428.
16. Isobe T, Hisaoka T, Shimizu A, et al. Propolypeptide of von Willebrand factor is a novel ligand for very late antigen-4 integrin. J Biol Chem. 1997;272:8447-8453.
17. Takahashi H, Isobe T, Horibe S, et al. Tissue transglutaminase, coagulation factor XIII, and the pro-polypeptide of von Willebrand factor are all ligands for the integrins α9β1 and α4β1. J Biol Chem. 2000;275:23589-23595.
18. Koivunen E, Ranta TM, Annila A, et al. Inhibition of beta(2) integrin-mediated leukocyte cell adhesion by leucine-leucine-glycine motif-containing peptides. J Cell Biol. 2001;153:905-916.
19. Lankhof H, Damas C, Schiphorst ME, et al. von Willebrand factor without the A2 domain is resistant to proteolysis. Thromb Haemost. 1997;77:1008-1013.
20. Lankhof H, van Hoeijj M, Schiphorst ME, et al. A3 domain is essential for interaction of von Willebrand factor with collagen type III. Thromb Haemost. 1996;75:950-958.
21. Lenting PJ, Westein E, Terraube V, et al. An experimental model to study the in vivo survival of von Willebrand factor: basic aspects and application to the R1205H mutation. J Biol Chem. 2004;279:12102-12109.
22. Ihanus E, Uotila L, Toivanen A, et al. Characterization of ICAM-4 binding to the I domains of the CD11a/CD18 and CD11b/CD18 leukocyte integrins. Eur J Biochem. 2003;270:1710-1723.
23. Kumar A, Villani MP, Patel UK, Keith JC Jr, Schaub RG. Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model. Circulation. 1999;99:1363-1369.
24. Fujimura Y, Titani K, Usami Y, et al. Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca. Biochemistry. 1991;19:1957-1964.
25. De Luca M, Dunlop LC, Andrews RK, et al. A novel cobra venom metalloproteinase, mocarhagin, cleaves a 10-amino acid peptide from the mature N terminus of P-selectin glycoprotein ligand receptor, PSGL-1, and abolishes P-selectin binding. J Biol Chem. 1995;270:26734-26737.
26. Ward CM, Andrews RK, Smith AI, Berndt MC. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibα: identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibα as a binding site for von Willebrand factor and alpha-thrombin. Biochemistry. 1996;35:4929-4938.
27. Kumar R, Camphausen RT, Sullivan FX, Cumming DA. Core2 beta-6-N-acetylglucosaminyltransferase enzyme activity is critical for P-selectin glycoprotein ligand-1 binding to P-selectin. Blood. 1996;88:3872-3879.
28. Billy D, Briede J, Heemskerk JW, Hemker HC, Lindhout T. Prothrombin conversion under flow conditions by prothrombinase assembled on adherent platelets. Blood Coagul Fibrinolysis. 1997;8:168-174.
29. Lo SK, Rahman A, Xu N, et al. Neutrophil inhibitory factor abrogates neutrophil adhesion by blockade of CD11a and CD11b beta(2) integrins. Mol Pharmacol. 1999;56:926-932.
30. McEver RP. Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost. 2001;86:746-756.
31. Hirata T, Furukawa Y, Yang BG, et al. Human Pselectin glycoprotein ligand-1 (PSGL-1) interacts with the skin-associated chemokine CCL27 via sulfated tyrosines at the PSGL-1 amino terminus. J Biol Chem. 2004;279:51775-51782.
32. Hicks AE, Nolan SL, Ridger VC, Hellewell PG, Norman KE. Recombinant P-selectin glycoprotein ligand-1 directly inhibits leukocyte rolling by all 3 selectins in vivo: complete inhibition of rolling is not required for anti-inflammatory effect. Blood. 2003;101:3249-3256.
33. Zheng PS, Vais D, Lapierre D, et al. PG-M/versican binds to P-selectin glycoprotein ligand-1 and mediates leukocyte aggregation. J Cell Sci. 2004;117:5887-5895.
34. Dong J, Ye P, Schade AJ, et al. Tyrosine sulfation of glycoprotein I(b)alpha: role of electrostatic interactions in von Willebrand factor binding. J Biol Chem. 2001;276:16690-16694.
35. Pouyani T, Seed B. PSGL-1 recognition of P-selectin is controlled by a tyrosine sulfation consensus at the PSGL-1 amino terminus. Cell. 1995;20:333-343.
36. Sako D, Comess KM, Barone KM, et al. A sulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding. Cell. 1995;20:323-331.
37. Liu W, Ramachandran V, Kang J, et al. Identification of N-terminal residues on P-selectin glycoprotein ligand-1 required for binding to P-selectin. J Biol Chem. 1998;20:7078-7087.
38. Rodgers SD, Camphausen RT, Hammer DA. Tyrosine sulfation enhances but is not required for PSGL-1 rolling adhesion on P-selectin. Biophys J. 2001;81:2001-2009.
39. Ehlers R, Ustinov V, Chen Z, et al. Targeting platelet-leukocyte interactions: identification of the integrin Mac-1 binding site for the platelet counter receptor glycoprotein Ibα. J Exp Med. 2003;198:1077-1088.
40. Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell. 1993;74:541-554.